SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Trager James

(Last)

(First)

(Middle)

C/O NKARTA, INC.

6000 SHORELINE COURT, SUITE 102

(Street)

SOUTH SAN FRANCISCO

94080

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/09/2020

3. Issuer Name and Ticker or Trading Symbol
Nkarta, Inc. [ NKTX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Scientific Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	48,422⁽⁴⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (right to buy)	⁽¹⁾	11/02/2026	Common Stock	5,630⁽⁴⁾	$0.04	D
Stock Option (right to buy)	⁽²⁾	09/05/2029	Common Stock	93,243⁽⁴⁾	$3.89	D
Stock Option (right to buy)	⁽³⁾	09/05/2029	Common Stock	62,162⁽⁴⁾	$3.89	D

Explanation of Responses:

1. The option is vested and exercisable as to 3,378 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on September 6, 2020.

2. The option is vested and exercisable as to 19,425 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023.

3. The option will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023.

4. Share numbers give effect to the 1-for-3.7 reverse stock split of each share of the Issuer's Common Stock, which became effective on July 1, 2020.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Matthew Plunkett, Attorney-in-Fact for James Trager	07/09/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.